{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:09:01Z","timestamp":1792271341521,"version":"4.4.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004569","name":"Ministerstwo Nauki i Szkolnictwa Wy\u017cszego","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s10096-022-04457-w","type":"journal-article","created":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T06:33:50Z","timestamp":1652942030000},"page":"961-969","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Antimicrobial resistance among Haemophilus influenzae isolates responsible for lower respiratory tract infections in Poland, 2005\u20132019"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2318-3375","authenticated-orcid":false,"given":"Marlena","family":"Kiedrowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2704-6186","authenticated-orcid":false,"given":"Weronika Jasmina","family":"Fory\u015b","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9662-8243","authenticated-orcid":false,"given":"Agnieszka","family":"Go\u0142\u0119biewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5494-3635","authenticated-orcid":false,"given":"Izabela","family":"Wa\u015bko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4427-5076","authenticated-orcid":false,"given":"Patrycja","family":"Ronkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5416-1422","authenticated-orcid":false,"given":"Alicja","family":"Kuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4726-5984","authenticated-orcid":false,"given":"Izabela","family":"Wr\u00f3bel-Pawelczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Wroczy\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3651-9790","authenticated-orcid":false,"given":"Waleria","family":"Hryniewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2247-830X","authenticated-orcid":false,"given":"Anna","family":"Skoczy\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,18]]},"reference":[{"key":"4457_CR1","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1016\/j.vaccine.2017.06.001","volume":"35","author":"RSW Tsang","year":"2017","unstructured":"Tsang RSW, Ulanova M (2017) The changing epidemiology of invasive Haemophilus influenzae disease: emergence and global presence of serotype a strains that may require a new vaccine for control. Vaccine 35:4270\u20134275. https:\/\/doi.org\/10.1016\/j.vaccine.2017.06.001","journal-title":"Vaccine"},{"key":"4457_CR2","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12866-020-01785-9","volume":"20","author":"PY Su","year":"2020","unstructured":"Su PY, Huang AH, Lai CH, Lin HF, Lin TM, Ho CH (2020) Extensively drug-resistant Haemophilus influenzae \u2013 emergence, epidemiology, risk factors, and regimen. BMC Microbiol 20:102. https:\/\/doi.org\/10.1186\/s12866-020-01785-9","journal-title":"BMC Microbiol"},{"key":"4457_CR3","doi-asserted-by":"crossref","unstructured":"Murphy TF (2015) Haemophilus species, including H. influenzae and H. ducreyi (Chancroid). In: Bennett JE, Dolin R, Blaser MJ Principles and Practice of infectious diseases, 8th edn. Philadelphia, PA, pp 2575\u20132578","DOI":"10.1016\/B978-1-4557-4801-3.00227-7"},{"key":"4457_CR4","unstructured":"(2017) Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis. World Health Organization. https:\/\/www.who.int\/medicines\/areas\/rational_use\/PPLreport_2017_09_19.pdf. Accessed 17 January 2022"},{"issue":"11","key":"4457_CR5","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.3390\/life11111260","volume":"11","author":"V Jakubu","year":"2021","unstructured":"Jakubu V, Malisova L, Musilek M, Pomorska K, Zemlickova H (2021) Characterization of Haemophilus influenzae strains with non-enzymatic resistance to \u03b2-lactam antibiotics caused by mutations in the PBP3 gene in the Czech Republic in 2010\u20132018. Life (Basel) 11(11):1260. https:\/\/doi.org\/10.3390\/life11111260","journal-title":"Life (Basel)"},{"issue":"22","key":"4457_CR6","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1016\/j.vaccine.2011.03.059","volume":"29","author":"M Giufr\u00e8","year":"2011","unstructured":"Giufr\u00e8 M, Cardines R, Caporali MG, Accogli M, D\u2019Ancona F, Cerquetti M (2011) Ten years of Hib vaccination in Italy: prevalence of non-encapsulated Haemophilus influenzae among invasive isolates and the possible impact on antibiotic resistance. Vaccine 29(22):3857\u20133862. https:\/\/doi.org\/10.1016\/j.vaccine.2011.03.059","journal-title":"Vaccine"},{"issue":"46","key":"4457_CR7","doi-asserted-by":"publisher","first-page":"6227","DOI":"10.1016\/j.vaccine.2015.09.082","volume":"33","author":"M Giufr\u00e8","year":"2015","unstructured":"Giufr\u00e8 M, Daprai L, Cardines R, Bernaschi P, Rav\u00e0 L, Accogli M, Raponi M, Garlaschi ML, CiofidegliAtti ML, Cerquetti M (2015) Carriage of Haemophilus influenzae in the oropharynx of young children and molecular epidemiology of the isolates after fifteen years of H influenzae type b vaccination in Italy. Vaccine 33(46):6227\u201334. https:\/\/doi.org\/10.1016\/j.vaccine.2015.09.082","journal-title":"Vaccine"},{"issue":"45","key":"4457_CR8","doi-asserted-by":"publisher","first-page":"6615","DOI":"10.1016\/j.vaccine.2018.09.060","volume":"36","author":"M Giufr\u00e8","year":"2018","unstructured":"Giufr\u00e8 M, Fabiani M, Cardines R, Riccardo F, Caporali MG, D\u2019Ancona F, Pezzotti P, Cerquetti M (2018) Increasing trend in invasive non-typeable Haemophilus influenzae disease and molecular characterization of the isolates, Italy, 2012\u20132016. Vaccine 36(45):6615\u20136622. https:\/\/doi.org\/10.1016\/j.vaccine.2018.09.060","journal-title":"Vaccine"},{"issue":"5","key":"4457_CR9","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1093\/jac\/dkw565","volume":"72","author":"RSW Tsang","year":"2017","unstructured":"Tsang RSW, Shuel M, Whyte K et al (2017) Antibiotic susceptibility and molecular analysis of invasive Haemophilus influenzae in Canada, 2007 to 2014. J Antimicrob Chemother 72(5):1314\u20131319. https:\/\/doi.org\/10.1093\/jac\/dkw565","journal-title":"J Antimicrob Chemother"},{"key":"4457_CR10","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/s0140-6736(75)91630-x","volume":"1","author":"AA Medeiros","year":"1975","unstructured":"Medeiros AA, O\u2019Brien TF (1975) Ampicillin-resistant Haemophilus influenzae type B possessing a TEM-type beta-lactamase but little permeability barrier to ampicillin. Lancet 1:716\u2013719. https:\/\/doi.org\/10.1016\/s0140-6736(75)91630-x","journal-title":"Lancet"},{"issue":"1","key":"4457_CR11","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1128\/AAC.17.1.80","volume":"17","author":"SM Markowitz","year":"1980","unstructured":"Markowitz SM (1980) Isolation of an ampicillin-resistant, non-beta-lactamase-producing strain of Haemophilus influenzae. Antimicrob Agents Chemother 17(1):80\u201383. https:\/\/doi.org\/10.1128\/AAC.17.1.80","journal-title":"Antimicrob Agents Chemother"},{"key":"4457_CR12","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1128\/CMR.00040-06","volume":"20","author":"S Tristram","year":"2007","unstructured":"Tristram S, Jacobs MR, Appelbaum PC (2007) Antimicrobial resistance in Haemophilus influenzae. Clin Microbiol Rev 20:368\u2013389. https:\/\/doi.org\/10.1128\/CMR.00040-06","journal-title":"Clin Microbiol Rev"},{"key":"4457_CR13","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1128\/AAC.45.6.1693-1699.2001","volume":"45","author":"K Ubukata","year":"2001","unstructured":"Ubukata K, Shibasaki Y, Yamamoto K, Chiba N, Hasegawa K, Takeuchi Y, Sunakawa K, Inoue M, Konno M (2001) Association of amino acid substitutions in penicillin-binding protein 3 with beta-lactam resistance in beta-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob Agents Chemother 45:1693\u20131699. https:\/\/doi.org\/10.1128\/AAC.45.6.1693-1699.2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"4457_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.00851-18","volume":"62","author":"H Honda","year":"2018","unstructured":"Honda H, Sato T, Shinagawa M et al (2018) Multiclonal expansion and high prevalence of \u03b2-lactamase-negative Haemophilus influenzae with high-level ampicillin resistance in japan and susceptibility to quinolones. Antimicrob Agents Chemother. 62(9):1\u201318. https:\/\/doi.org\/10.1128\/AAC.00851-18","journal-title":"Antimicrob Agents Chemother."},{"issue":"8","key":"4457_CR15","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1007\/s10096-020-03865-0","volume":"39","author":"Heliodoro CIM, Bettencourt CR, Bajanca-Lavado MP; Portuguese Group for the Study of Haemophilus influenzae invasive infection","year":"2020","unstructured":"Heliodoro CIM, Bettencourt CR, Bajanca-Lavado MP; Portuguese Group for the Study of Haemophilus influenzae invasive infection (2020) Molecular epidemiology of invasive Haemophilus influenzae disease in Portugal: an update of the post-vaccine period, 2011\u20132018. Eur J Clin Microbiol Infect Dis 39(8):1471\u20131480. https:\/\/doi.org\/10.1007\/s10096-020-03865-0","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4457_CR16","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1469-0691.2007.01664.x","volume":"13","author":"A Skoczy\u0144ska","year":"2007","unstructured":"Skoczy\u0144ska A, Kad\u0142ubowski M, Wa\u015bko I, Fiett J, Hryniewicz W (2007) Resistance patterns of selected respiratory tract pathogens in Poland. Clin Microbiol Infect 13:377\u2013383. https:\/\/doi.org\/10.1111\/j.1469-0691.2007.01664.x","journal-title":"Clin Microbiol Infect"},{"key":"4457_CR17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jgar.2017.08.005","volume":"11","author":"M Kiedrowska","year":"2017","unstructured":"Kiedrowska M, Kuch A, \u017babicka D, Wa\u015bko I, Ronkiewicz P, Wasiak K, Bojarska K, Hryniewicz W, Skoczy\u0144ska A (2017) \u03b2-Lactam resistance among Haemophilus influenzae isolates in Poland. J Glob Antimicrob Resist 11:161\u2013166. https:\/\/doi.org\/10.1016\/j.jgar.2017.08.005","journal-title":"J Glob Antimicrob Resist"},{"key":"4457_CR18","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1093\/jac\/dkq533","volume":"66","author":"AR Barbosa","year":"2011","unstructured":"Barbosa AR, Giufr\u00e8 M, Cerquetti M, Bajanca-Lavado MP (2011) Polymorphism in ftsI gene and {beta}-lactam susceptibility in Portuguese Haemophilus influenzae strains: clonal dissemination of beta-lactamase-positive isolates with decreased susceptibility to amoxicillin\/clavulanic acid. J Antimicrob Chemother 66:788\u2013796. https:\/\/doi.org\/10.1093\/jac\/dkq533","journal-title":"J Antimicrob Chemother"},{"key":"4457_CR19","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.ijmm.2015.08.028","volume":"305","author":"TT L\u00e2m","year":"2015","unstructured":"L\u00e2m TT, Claus H, Elias J, Frosch M, Vogel U (2015) Ampicillin resistance of invasive Haemophilus influenzae isolates in Germany 2009\u20132012. Int J Med Microbiol 305:748\u2013755. https:\/\/doi.org\/10.1016\/j.ijmm.2015.08.028","journal-title":"Int J Med Microbiol"},{"key":"4457_CR20","doi-asserted-by":"crossref","unstructured":"Deghmane AE, Hong E, Chehboub S, Terrade A, Falgui\u00e8res M, Sort M, Harrison O, Jolley KA, Taha MK 2019 High diversity of invasive Haemophilus influenzae isolates in France and the emergence of resistance to third generation cephalosporins by alteration of ftsI gene. J Infect 79:7\u201314. 1016\/j.jinf.2019.05.007","DOI":"10.1016\/j.jinf.2019.05.007"},{"issue":"3","key":"4457_CR21","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.diagmicrobio.2018.10.009","volume":"93","author":"L Schotte","year":"2019","unstructured":"Schotte L, Wautier M, Martiny D, Pi\u00e9rard D, Depypere M (2019) Detection of beta-lactamase-negative ampicillin resistance in Haemophilus influenzae in Belgium. Diagn Microbiol Infect Dis 93(3):243\u2013249. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2018.10.009","journal-title":"Diagn Microbiol Infect Dis"},{"key":"4457_CR22","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST). (Version 11.0. 2021) Breakpoint tables for interpretations of MICs and zone diameters: 60\u201365. https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/v_11.0_Breakpoint_Tables.pdf."},{"issue":"1","key":"4457_CR23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1089\/107662903764736337","volume":"9","author":"K Hasegawa","year":"2003","unstructured":"Hasegawa K, Yamamoto K, Chiba N et al (2003) Diversity of ampicillin-resistance genes in Haemophilus influenzae in Japan and the United States. Microb Drug Resist 9(1):39\u201346. https:\/\/doi.org\/10.1089\/107662903764736337","journal-title":"Microb Drug Resist"},{"key":"4457_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1017\/s0950268800051943","volume":"114","author":"RP Hobson","year":"1995","unstructured":"Hobson RP, Williams A, Rawal K, Pennington TH, Forbes KJ (1995) Incidence and spread of Haemophilus influenzae on an Antarctic base determined using the polymerase chain reaction. Epidemiol Infect 114:93\u2013103. https:\/\/doi.org\/10.1017\/s0950268800051943","journal-title":"Epidemiol Infect"},{"issue":"4","key":"4457_CR25","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1128\/JCM.41.4.1623-1636.2003","volume":"41","author":"E Meats","year":"2003","unstructured":"Meats E, Feil EJ, Stringer S et al (2003) Characterization of encapsulated and noncapsulated Haemophilus influenzae and determination of phylogenetic relationships by multilocus sequence typing. J Clin Microbiol 41(4):1623\u20131636. https:\/\/doi.org\/10.1128\/JCM.41.4.1623-1636.2003","journal-title":"J Clin Microbiol"},{"issue":"7","key":"4457_CR26","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1128\/AAC.49.7.2834-2839.2005","volume":"49","author":"Y Osaki","year":"2005","unstructured":"Osaki Y, Sanbongi Y, Ishikawa M et al (2005) Genetic approach to study the relationship between penicillin-binding protein 3 mutations and Haemophilus influenzae beta-lactam resistance by using site-directed mutagenesis and gene recombinants. Antimicrob Agents Chemother 49(7):2834\u20132839. https:\/\/doi.org\/10.1128\/AAC.49.7.2834-2839.2005","journal-title":"Antimicrob Agents Chemother"},{"key":"4457_CR27","doi-asserted-by":"publisher","first-page":"20986","DOI":"10.2807\/1560-7917.es2014.19.49.20986","volume":"19","author":"D Skaare","year":"2014","unstructured":"Skaare D, Anthonisen IL, Kahlmeter G, Matuschek E, Nat\u00e5s OB, Steinbakk M, Sundsfjord A, Kristiansen BE (2014) Emergence of clonally related multidrug resistant Haemophilus influenzae with penicillin-binding protein 3-mediated resistance to extended-spectrum cephalosporins, Norway, 2006 to 2013. Euro Surveill 19:20986. https:\/\/doi.org\/10.2807\/1560-7917.es2014.19.49.20986","journal-title":"Euro Surveill"},{"issue":"4","key":"4457_CR28","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.jiph.2019.11.003","volume":"13","author":"S Yamada","year":"2020","unstructured":"Yamada S, Seyama S, Wajima T, Yuzawa Y, Saito M, Tanaka E, Noguchi N (2020) \u03b2-Lactamase-non-producing ampicillin-resistant Haemophilus influenzae is acquiring multidrug resistance. J Infect Public Health 13(4):497\u2013501. https:\/\/doi.org\/10.1016\/j.jiph.2019.11.003","journal-title":"J Infect Public Health"},{"issue":"6","key":"4457_CR29","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1093\/jac\/dkh467","volume":"54","author":"M Cerquetti","year":"2004","unstructured":"Cerquetti M, Cardines R, Giufr\u00e8 M, Mastrantonio P, Hi Study Group (2004) Antimicrobial susceptibility of Haemophilus influenzae strains isolated from invasive disease in Italy. J Antimicrob Chemother 54(6):1139\u20131143. https:\/\/doi.org\/10.1093\/jac\/dkh467","journal-title":"J Antimicrob Chemother"},{"key":"4457_CR30","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1128\/AAC.01316-05","volume":"50","author":"Y Sanbongi","year":"2006","unstructured":"Sanbongi Y, Suzuki T, Osaki Y, Senju N, Ida T, Ubukata K (2006) Molecular evolution of beta-lactam-resistant Haemophilus influenzae: 9-year surveillance of penicillin-binding protein 3 mutations in isolates from Japan. Antimicrob Agents Chemother 50:2487\u20132492. https:\/\/doi.org\/10.1128\/AAC.01316-05","journal-title":"Antimicrob Agents Chemother"},{"key":"4457_CR31","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1128\/AAC.00354-07","volume":"51","author":"S Garc\u00eda-Cobos","year":"2007","unstructured":"Garc\u00eda-Cobos S, Campos J, L\u00e1zaro E, Rom\u00e1n F, Cercenado E, Garc\u00eda-Rey C, P\u00e9rez-V\u00e1zquez M, Oteo J, de Abajo F (2007) Ampicillin-resistant non-beta-lactamase-producing Haemophilus influenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime. Antimicrob Agents Chemother 51:2564\u20132573. https:\/\/doi.org\/10.1128\/AAC.00354-07","journal-title":"Antimicrob Agents Chemother"},{"key":"4457_CR32","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1128\/aac.47.6.1875-1881.2003","volume":"47","author":"GG Zhanel","year":"2003","unstructured":"Zhanel GG, Palatnick L, Nichol KA, Low DE, Hoban DJ (2003) CROSS Study Group. Antimicrobial resistance in Haemophilus influenzae and Moraxella catarrhalis respiratory tract isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002. Antimicrob Agents Chemother 47:1875\u20131881. https:\/\/doi.org\/10.1128\/aac.47.6.1875-1881.2003","journal-title":"Antimicrob Agents Chemother"},{"key":"4457_CR33","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.jiac.2019.02.010","volume":"25","author":"A Mizoguchi","year":"2019","unstructured":"Mizoguchi A, Hitomi S (2019) Cefotaxime-non-susceptibility of Haemophilus influenzae induced by additional amino acid substitutions of G555E and Y557H in altered penicillin-binding protein 3. J Infect Chemother 25:509\u2013513. https:\/\/doi.org\/10.1016\/j.jiac.2019.02.010","journal-title":"J Infect Chemother"},{"key":"4457_CR34","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1007\/s10096-018-3273-z","volume":"37","author":"A Aguirre-Qui\u00f1onero","year":"2018","unstructured":"Aguirre-Qui\u00f1onero A, P\u00e9rez Del Molino IC, de la Fuente CG, Sanju\u00e1n MC, Ag\u00fcero J, Mart\u00ednez-Mart\u00ednez L (2018) Phenotypic detection of clinical isolates of Haemophilus influenzae with altered penicillin-binding protein 3. Eur J Clin Microbiol Infect Dis 37:1475\u20131480. https:\/\/doi.org\/10.1007\/s10096-018-3273-z","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"4457_CR35","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1177\/106002809302700311","volume":"27","author":"SL Barriere","year":"1993","unstructured":"Barriere SL, Hindler JA (1993) Ciprofloxacin-resistant Haemophilus influenzae infection in a patient with chronic lung disease. Ann Pharmacother 27(3):309\u2013310. https:\/\/doi.org\/10.1177\/106002809302700311","journal-title":"Ann Pharmacother"},{"key":"4457_CR36","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.3201\/eid2008.140341","volume":"20","author":"SC Kuo","year":"2014","unstructured":"Kuo SC, Chen PC, Shiau YR, Wang HY, Lai JF 1st, Huang W, Lauderdale TL (2014) Levofloxacin-resistant Haemophilus influenzae, Taiwan, 2004\u20132010. Emerg Infect Dis 20:1386\u20131390. https:\/\/doi.org\/10.3201\/eid2008.140341","journal-title":"Emerg Infect Dis"},{"key":"4457_CR37","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1128\/AAC.01437-06","volume":"51","author":"M P\u00e9rez-V\u00e1zquez","year":"2007","unstructured":"P\u00e9rez-V\u00e1zquez M, Rom\u00e1n F, Garc\u00eda-Cobos S, Campos J (2007) Fluoroquinolone resistance in Haemophilus influenzae is associated with hypermutability. Antimicrob Agents Chemother 51:1566\u20131569. https:\/\/doi.org\/10.1128\/AAC.01437-06","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"4457_CR38","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/jac\/dkg049","volume":"51","author":"M P\u00e9rez-V\u00e1zquez","year":"2003","unstructured":"P\u00e9rez-V\u00e1zquez M, Rom\u00e1n F, Varela MC, Cant\u00f3n R, Campos J (2003) Activities of 13 quinolones by three susceptibility testing methods against a collection of Haemophilus influenzae isolates with different levels of susceptibility to ciprofloxacin: evidence for cross-resistance. J Antimicrob Chemother 51(1):147\u2013151. https:\/\/doi.org\/10.1093\/jac\/dkg049","journal-title":"J Antimicrob Chemother"},{"key":"4457_CR39","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/s0732-8893(03)00016-6","volume":"46","author":"DJ Biedenbach","year":"2003","unstructured":"Biedenbach DJ, Jones RN (2003) Five-year analysis of Haemophilus influenzae isolates with reduced susceptibility to fluoroquinolones: prevalence results from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis 46:55\u201361. https:\/\/doi.org\/10.1016\/s0732-8893(03)00016-6","journal-title":"Diagn Microbiol Infect Dis"},{"key":"4457_CR40","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1128\/AAC.01548-09","volume":"54","author":"E P\u00e9rez-Trallero","year":"2010","unstructured":"P\u00e9rez-Trallero E, Mart\u00edn-Herrero JE, Maz\u00f3n A, Garc\u00eda-Delafuente C, Robles P, Iriarte V, Dal-R\u00e9 R, Garc\u00eda-de-Lomas J (2010) Spanish Surveillance Group for Respiratory Pathogens. Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996\u20131997 to 2006\u20132007). Antimicrob Agents Chemother 54:2953\u20132959. https:\/\/doi.org\/10.1128\/AAC.01548-09","journal-title":"Antimicrob Agents Chemother"},{"key":"4457_CR41","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1128\/AAC.04005-14","volume":"59","author":"C Puig","year":"2015","unstructured":"Puig C, Tirado-V\u00e9lez JM, Calatayud L, Tubau F, Garmendia J, Ardanuy C, Marti S, de la Campa AG, Li\u00f1ares J (2015) Molecular characterization of fluoroquinolone resistance in nontypeable Haemophilus influenzae clinical isolates. Antimicrob Agents Chemother 59:461\u2013466. https:\/\/doi.org\/10.1128\/AAC.04005-14","journal-title":"Antimicrob Agents Chemother"},{"key":"4457_CR42","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1128\/AAC.00192-09","volume":"53","author":"Y Hirakata","year":"2009","unstructured":"Hirakata Y, Ohmori K, Mikuriya M, Saika T, Matsuzaki K, Hasegawa M, Hatta M, Yamamoto N, Kunishima H, Yano H, Kitagawa M, Arai K, Kawakami K, Kobayashi I, Jones RN, Kohno S, Yamaguchi K, Kaku M (2009) Antimicrobial activities of piperacillin-tazobactam against Haemophilus influenzae isolates, including beta-lactamase-negative ampicillin-resistant and beta-lactamase-positive amoxicillin-clavulanate-resistant isolates, and mutations in their quinolone resistance-determining regions. Antimicrob Agents Chemother 53:4225\u20134230. https:\/\/doi.org\/10.1128\/AAC.00192-09","journal-title":"Antimicrob Agents Chemother"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-022-04457-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-022-04457-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-022-04457-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T12:14:19Z","timestamp":1653567259000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-022-04457-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,18]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["4457"],"URL":"https:\/\/doi.org\/10.1007\/s10096-022-04457-w","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,18]]},"assertion":[{"value":"3 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted as continuous surveillance in accordance with the World Health Medical Association 1966 Declaration of Helsinki and the EU rules of Good Clinical Practice.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}